We Do Data Right.

Liver Matters

Liver
Matters

Help us push the frontiers of liver research across rare and chronic liver diseases by bringing together a pre-competitive consortium of pharma collaborators
to create a geographically diverse liver-focused registry across North America and Europe.

Sub-Study
Ready

Configuration is part of our DNA. To support sub-studies of interest to sponsors, the core platform is natively built to be configured with ease with the depth of study workflow and the user experience demanded by modern consumers.

liver matters

We enable evidence generation throughout the lifecycle of a molecule

  • Natural History Data
  • Deepen relationships with expert researcher
  • Inform pipeline prioritization 
  • Inform trial design
  • Develop clinical endpoints
  • Define and create comparator arms

 

  • Capture QoL data
  • External control arms
  • Market Access studies
  • Reimbursement & Payor evidence
  • Long-Term Follow-Up
  • Safety and REMS studies

A Robust Foundation of Real-World Data

By initially launching with ePROs and subsequently providing the option to expand into clinical, phenotypic and biomarker data, we offer sponsors a pragmatic platform that not only augments research but also enhances the understanding of disease, improves clinical trial performance, and ultimately strengthens  treatment effectiveness.

Social listening capabilities to further refine insights gathered remotley.

Disease-specific data Elements, including PBC and MASH. Omics data also supported.

The Pulse Platform framework supports adding sub-studies and additional sites alongside ongoing remote data collection. (eCOAs, eCRFs)

Ready to learn More?